424B3 1 ss72373_424b3-europe.htm
PROSPECTUS SUPPLEMENT
REGISTRATION NO.  333-44286
(To Prospectus dated March 11, 2009)
Filed Pursuant to Rule 424(b)(3)
 
 

1,000,000,000 Depositary Receipts
Europe 2001 HOLDRS (SM) Trust

This prospectus supplement supplements information contained in the prospectus dated March 11, 2009 relating to the sale of up to 1,000,000,000 depositary receipts by the Europe 2001 HOLDRS Trust.
 
The share amounts specified in the table in the “Highlights of Europe 2001 HOLDRS” section of the base prospectus shall be replaced with the following:
 
 
Name of Company1
 
 
Ticker
  
 
Share
Amounts
  
 
Primary U.S.
Trading
Market
AEGON N.V.
  
AEG
  
5.2000
  
NYSE
Alcatel-Lucent*
  
ALU
  
3.0000
  
NYSE
Amdocs Limited
  
DOX
  
3.0000
  
NYSE
ARM Holdings, plc*
  
ARMH
  
8.0000
  
NASDAQ
ASM International N.V.
  
ASMI
  
13.0000
  
NASDAQ
ASML Holding N.V.
  
ASML
  
6.2222
  
NASDAQ
AstraZeneca PLC.*
  
AZN
  
4.0000
  
NYSE
AXA*
  
AXA
  
6.0000
  
NYSE
BP p.l.c.*
  
BP
  
4.0000
  
NYSE
Daimler AG
  
DAI
  
4.0000
  
NYSE
Deutsche Telekom AG*
  
DT
  
5.0000
  
NYSE
Diageo p.l.c.*
  
DEO
  
5.0000
  
NYSE
Elan Corporation, p.l.c.*
  
ELN
  
4.0000
  
NYSE
LM Ericsson Telephone Company*
  
ERIC
  
3.2000
  
NASDAQ
GlaxoSmithKline p.l.c.*
  
GSK
  
6.0000
  
NYSE
ING Groep N.V.*
  
ING
  
4.0000
  
NYSE
Koninklijke Philips Electronics N.V.
  
PHG
  
5.0000
  
NYSE
Millicom International Cellular S.A.*
  
MICC
  
8.0000
  
NASDAQ

(continued on following page)
 
1 Effective April 28, 2009, Bookham Inc. (NASDAQ Ticker “BKHM”), an underlying constituent of the Europe 2001 HOLDRS Trust, changed its name to Oclaro Inc. (NASDAQ Ticker “OCLR”).  As a result, effective May 1, 2009, creations of Europe 2001 HOLDRS require a deposit of 1.2 shares of Oclaro Inc. per round lot of 100 Europe 2001 HOLDRS.
 
 
 
 
 
Name of Company
  
Ticker
  
Share
Amounts
  
Primary U.S.
Trading
Market
Nokia Corporation*
  
NOK
  
5.0000
  
NYSE
Novartis AG*
  
NVS
  
5.0000
  
NYSE
Oclaro Inc.
  
OCLR
  
1.2000
  
NASDAQ
Qiagen N.V.
  
QGEN
  
6.0000
  
NASDAQ
Repsol YPF, S.A.*
  
REP
  
11.000
  
NYSE
Ryanair Holdings p.l.c.*
  
RYAAY
  
16.0000
  
NASDAQ
Sanofi-Aventis SA*
  
SNY
  
4.6956
  
NYSE
SAP AG*
  
SAP
  
4.0000
  
NYSE
Shire plc*
  
SHPGY
  
4.0000
  
NASDAQ
Skillsoft p.l.c.*
  
SKIL
  
6.0000
  
NASDAQ
STMicroelectronics N.V.
  
STM
  
4.0000
  
NYSE
Telefonica S.A.*
  
TEF
  
4.5558
  
NYSE
Total S.A.*
  
TOT
  
6.0000
  
NYSE
UBS AG
  
UBS
  
6.3000
  
NYSE
Unilever N.V.
  
UN
  
9.0000
  
NYSE
Vodafone Group Public Limited Company*
  
VOD
  
5.2500
  
NYSE
WPP Group p.l.c.
  
WPPGY
  
3.0000
  
NASDAQ
 
 
*  The securities of these non-U.S. companies trade in the United States as American Depository Receipts.  Please see “Risk Factors” and “U.S. Federal Income Tax Consequences—Special considerations with respect to underlying securities of foreign issuers” for additional information relating to an investment in a non-U.S. company.
 

The share amounts listed in the table above reflect all previous stock splits, dividends and business combination transactions.
 
The date of this prospectus supplement is September 15, 2009.